Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma

The outcomes of patients treated with surgery for early stage pancreatic ductal adenocarcinoma (PDAC) are variable with median survival ranging from 6 months to more than 5 years. This challenge underscores an unmet need for developing personalized medicine strategies to refine the current treatment...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Chen, Dung-Tsa, Davis-Yadley, Ashley H., Huang, Po-Yu, Husain, Kazim, Centeno, Barbara A., Permuth-Wey, Jennifer, Pimiento, Jose M., Malafa, Mokenge
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2015
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527782/
https://ncbi.nlm.nih.gov/pubmed/26247463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0133562
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg